DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH
Delisted
DCPH was delisted on the 10th of June, 2024.
150 hedge funds and large institutions have $885M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 59 increasing their positions, 34 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
18% more funds holding
Funds holding: 127 → 150 (+23)
Holders
150
Holding in Top 10
2
Calls
$8.3M
Puts
–
Top Buyers
| 1 | +$28.5M | |
| 2 | +$12.9M | |
| 3 | +$12.4M | |
| 4 |
D.E. Shaw & Co
New York
|
+$11.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$10.5M |
Top Sellers
| 1 | -$69.6M | |
| 2 | -$13.2M | |
| 3 | -$12.7M | |
| 4 |
AC
Armistice Capital
New York
|
-$11.7M |
| 5 |
JG
Jefferies Group
New York
|
-$9.54M |